A detailed history of Shell Asset Management CO transactions in Guardant Health, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 2,940 shares of GH stock, worth $99,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,940
Previous 3,107 5.37%
Holding current value
$99,254
Previous $90,000 25.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$22.3 - $36.29 $3,724 - $6,060
-167 Reduced 5.37%
2,940 $67,000
Q1 2024

Jul 31, 2024

SELL
$17.13 - $26.91 $702 - $1,103
-41 Reduced 1.3%
3,107 $90,000
Q1 2024

May 14, 2024

SELL
$17.13 - $26.91 $3,700 - $5,812
-216 Reduced 6.42%
3,148 $65,000
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $21,838 - $29,854
-1,012 Reduced 23.13%
3,364 $91,000
Q3 2023

Nov 08, 2023

SELL
$25.8 - $39.97 $1,780 - $2,757
-69 Reduced 1.55%
4,376 $130,000
Q2 2023

Jul 28, 2023

SELL
$20.94 - $38.01 $544 - $988
-26 Reduced 0.58%
4,445 $159,000
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $366 - $540
-16 Reduced 0.36%
4,471 $105,000
Q4 2022

Feb 07, 2023

SELL
$25.44 - $59.78 $22,361 - $52,546
-879 Reduced 16.38%
4,487 $122,000
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $61,691 - $86,193
-1,413 Reduced 20.84%
5,366 $289,000
Q2 2022

Aug 09, 2022

BUY
$28.82 - $77.35 $172 - $464
6 Added 0.09%
6,779 $273,000
Q1 2022

May 04, 2022

SELL
$48.25 - $100.49 $48,539 - $101,092
-1,006 Reduced 12.93%
6,773 $449,000
Q4 2021

Feb 09, 2022

BUY
$88.71 - $120.43 $3,903 - $5,298
44 Added 0.57%
7,779 $778,000
Q3 2021

Nov 04, 2021

SELL
$98.77 - $132.17 $32,594 - $43,616
-330 Reduced 4.09%
7,735 $967,000
Q2 2021

Aug 12, 2021

BUY
$109.77 - $165.68 $885,295 - $1.34 Million
8,065 New
8,065 $1 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.45B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.